查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1750733

自体免疫疾病诊断市场规模、份额、趋势分析报告：按类型、产品类型、测试类型、最终用途、地区、细分市场预测，2025-2030 年

Autoimmune Disease Diagnostics Market Size, Share & Trends Analysis Report By Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics), By Product, By Test Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 129 Pages | 商品交期: 2-10个工作天内

价格

自体免疫疾病诊断市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球自体免疫疾病诊断市场规模预计到2030年将达到82亿美元，2025年至2030年期间的复合年增长率为6.18%。

政府机构和组织正在努力控制这些高昂的医疗保健成本，同时为患者提供更好的诊断和治疗方案，从而增加美国国立卫生研究院对自体免疫疾病相关研究和开发项目的资金。

此外，政府推出的旨在遏制这些疾病发生和开发可行的诊断和治疗方案的有利倡议预计将在预测期内推动市场成长。

自体免疫诊断程序的兴起，使得对能够更快、更有效地提供结果的仪器和设备的需求日益增长。为了应对不断增长的程序量，诊断实验室正在迅速走向自动化。实验室自动化有助于减少工作量，缩短週转时间，并有助于获得标准化、可重复的结果。

自体免疫疾病诊断市场报告重点

  • 局部自体免疫疾病诊断领域将占据市场主导地位，到 2024 年的收入份额将达到 64.25%。
  • 2024 年，消耗品和检测试剂部门占据了最大的收益占有率，为 70.43%。所有临床实验室诊断测试都使用测试套件、试剂和抗体。
  • 按测试类型划分，抗核抗体测试占据市场主导地位，2024 年的收益占有率为 42.62%。该细分市场的成长受到可负担性、高灵敏度和充足可用性的推动。
  • 医院部门在市场中占据主导地位，2024 年的收益占有率为 53.32%。这一高份额归因于医院越来越多地采用自体免疫疾病诊断来治疗各种疾病。
  • 预计北美将主导全球自体免疫疾病诊断市场，2024 年的收入份额将达到自体免疫%。预计亚太地区在 2024 年至 2030 年期间的复合年增长率最快。

目录

第一章调查方法与范围

第二章执行摘要

第三章市场变数、趋势和范围

  • 市场展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析

第四章 业务类型分析

  • 自体免疫疾病诊断市场：按类型变化分析
  • 系统性自体免疫疾病的诊断
    • 系统性自体免疫疾病诊断市场，2018-2030
    • 类风湿性关节炎的诊断
    • 僵直性脊椎炎的诊断
    • 全身性红斑性狼疮（SLE）的诊断
    • 其他系统性自体免疫疾病的诊断
  • 局部疾病诊断
    • 2018-2030年局部疾病诊断市场
    • 多发性硬化症的诊断
    • 1型糖尿病的诊断
    • 桥本甲状腺炎的诊断
    • 特发性血小板减少紫斑症（ITP）的诊断
    • 其他局部自体免疫疾病的诊断

第五章 产品类型业务分析

  • 自体免疫疾病诊断市场：按产品类型进行的变化分析
  • 装置
  • 耗材和检测试剂

6. 按测试类型进行的业务分析

  • 自体免疫疾病诊断市场：按测试类型波动分析
  • 抗核抗体检测
  • 自体抗体检测
  • C反应蛋白（CRP）
  • 全血球计数（CBC）
  • 尿液检查
  • 其他的

第七章 按最终用途分類的业务分析

  • 自体免疫疾病诊断市场：依最终用途进行的变化分析
  • 医院
  • 诊断中心
  • 其他的

第八章区域业务分析

  • 2024 年及 2030 年各地区自体免疫疾病诊断市场占有率
  • 北美洲
    • SWOT分析
    • 2018-2030年北美自体免疫疾病诊断市场
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • SWOT分析
    • 2018-2030年欧洲自体免疫疾病诊断市场
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • SWOT分析
    • 2018-2030年亚太地区自体自体免疫疾病诊断市场
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • SWOT分析
    • 2018-2030年拉丁美洲自体免疫疾病诊断市场
    • 巴西
    • 阿根廷
  • 中东和非洲
    • SWOT分析
    • 2018-2030年中东及非洲自体免疫疾病诊断市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 公司分类
  • 战略地图
  • 2024年公司市场占有率分析
  • 公司简介/上市公司
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthcare Private Limited
    • Abbott
    • Beckman Coulter, Inc.
    • Danaher Corporation
    • Quest Diagnostics
    • EUROIMMUN Medizinische Labordiagnostika AG
    • Nova Diagnostics Pte Ltd.
    • BIOMERIEUX
    • Hemagen Diagnostics, Inc.
Product Code: 978-1-68038-292-1

Autoimmune Disease Diagnostics Market Growth & Trends:

The global autoimmune disease diagnostics market size is estimated to reach USD 8.20 billion by 2030, expanding at a CAGR of 6.18% from 2025 to 2030, according to a new report by Grand View Research, Inc. Government organizations along with related associations strive to curb such high healthcare costs and simultaneously provide improved diagnostic and therapeutic solutions to the patients. This has resulted in increased funding by the NIH for R&D programs related to autoimmune diseases.

Moreover, the presence of favorable government initiatives aimed at curbing the incidence of these diseases and developing viable diagnostic & treatment options is expected to drive market growth over the forecast period.

Growing volume of autoimmune diagnostic procedures has heightened the need for instruments and facilities rendering faster and effective results. In an attempt to cater to ever-increasing procedure volumes, diagnostic laboratories are rapidly moving toward automation. Lab automation helps decrease workload via rapid turnaround times and helps generate standardized & reproducible results.

Autoimmune Disease Diagnostics Market Report Highlights:

  • The localized autoimmune disease diagnostics segment dominated the market and accounted for a revenue share of 64.25% in 2024.
  • The consumables & assays segment accounted for the largest revenue share of 70.43% in 2024. Every laboratory diagnostic test utilizes test kits, reagents, and antibodies.
  • In terms of test type, the antinuclear antibody tests dominated the market with a revenue share of 42.62% in 2024. The growth of this segment is attributed to affordability, high sensitivity, and extensive availability.
  • The hospital segment dominated the market in 2024 with a revenue share of 53.32%. The high share is attributed to the increased adoption of autoimmune disease diagnostic practices in hospitals for various diseases.
  • The North America autoimmune disease diagnostics market dominated the global industry and accounted for a revenue share of 42.70% in 2024. The Asia Pacific autoimmune disease diagnostics market is anticipated to witness a fastest CAGR from 2024 to 2030.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Type segment
      • 1.1.1.2. Product segment
      • 1.1.1.3. Test Type segment
      • 1.1.1.4. End use segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Type and Test Type Snapshot
  • 2.3. Product and End Use Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Presence of research funding programs
      • 3.2.1.2. Presence of favorable government initiatives
      • 3.2.1.3. Growing patient awareness levels
      • 3.2.1.4. Technological innovation in the form of lab automation
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Slow diagnostic result turnaround times and lack of skilled healthcare practitioners
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Type Business Analysis

  • 4.1. Autoimmune Disease Diagnostics Market: Type Movement Analysis
  • 4.2. Systemic Autoimmune Disease Diagnostics
    • 4.2.1. Systemic Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 4.2.2. Rheumatoid Arthritis Diagnostics
      • 4.2.2.1. Rheumatoid Arthritis Diagnostics Market, 2018 - 2030 (USD Million)
    • 4.2.3. Ankylosing Spondylitis Diagnostics
      • 4.2.3.1. Ankylosing Spondylitis Diagnostics Market, 2018 - 2030 (USD Million)
    • 4.2.4. Systemic Lupus Erythematosus (SLE) Diagnostics
      • 4.2.4.1. Systemic Lupus Erythematosus (SLE) Diagnostics Market, 2018 - 2030 (USD Million)
    • 4.2.5. Other Systemic Autoimmune Disease Diagnostics
      • 4.2.5.1. Other Systemic Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 4.3. Localized Disease Diagnostics
    • 4.3.1. Localized Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 4.3.2. Multiple sclerosis diagnostics
      • 4.3.2.1. Multiple Sclerosis Diagnostics Market, 2018 - 2030 (USD Million)
    • 4.3.3. Type 1 Diabetes Diagnostics
      • 4.3.3.1. Type 1 Diabetes Diagnostics Market, 2018 - 2030 (USD Million)
    • 4.3.4. Hashimoto's Thyroiditis Diagnostics
      • 4.3.4.1. Hashimoto's Thyroiditis Diagnostics Market, 2018 - 2030 (USD Million)
    • 4.3.5. Idiopathic Thrombocytopenic Purpura (ITP) diagnostics
      • 4.3.5.1. Idiopathic Thrombocytopenic Purpura (ITP) diagnostics Market, 2018 - 2030 (USD Million)
    • 4.3.6. Other Localized Autoimmune Disease Diagnostics
      • 4.3.6.1. Other Localized Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)

Chapter 5. Product Business Analysis

  • 5.1. Autoimmune Disease Diagnostics Market: Product Movement Analysis
  • 5.2. Instruments
    • 5.2.1. Instruments Market, 2018 - 2030 (USD Million)
  • 5.3. Consumables and Assays
    • 5.3.1. Consumables and Assays Market, 2018 - 2030 (USD Million)

Chapter 6. Test Type Business Analysis

  • 6.1. Autoimmune Disease Diagnostics Market: Test Type Movement Analysis
  • 6.2. Antinuclear Antibody Tests
    • 6.2.1. Antinuclear Antibody Tests Market, 2018 - 2030 (USD Million)
  • 6.3. Autoantibody Tests
    • 6.3.1. Autoantibody Tests Market, 2018 - 2030 (USD Million)
  • 6.4. C-reactive Protein (CRP)
    • 6.4.1. C-Reactive Protein (CRP) Market, 2018 - 2030 (USD Million)
  • 6.5. Complete Blood Count (CBC)
    • 6.5.1. Complete Blood Count (CBC) Market, 2018 - 2030 (USD Million)
  • 6.6. Urinalysis
    • 6.6.1. Urinalysis Market, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. End Use Business Analysis

  • 7.1. Autoimmune Disease Diagnostics Market: End Use Movement Analysis
  • 7.2. Hospitals
    • 7.2.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 7.3. Diagnostic Centers
    • 7.3.1. Diagnostic Centers Market, 2018 - 2030 (USD Million)
  • 7.4. Others
    • 7.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Autoimmune Disease Diagnostics Market Share By Region, 2024 & 2030
  • 8.2. North America
    • 8.2.1. SWOT Analysis
    • 8.2.2. North America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.2.3. U.S.
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Regulatory Framework
      • 8.2.3.5. U.S. Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.2.4. Canada
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Target Disease Prevalence
      • 8.2.4.3. Competitive Scenario
      • 8.2.4.4. Regulatory Framework
      • 8.2.4.5. Canada Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.2.5. Mexico
      • 8.2.5.1. Key Country Dynamics
      • 8.2.5.2. Target Disease Prevalence
      • 8.2.5.3. Competitive Scenario
      • 8.2.5.4. Regulatory Framework
      • 8.2.5.5. Mexico Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. SWOT Analysis
    • 8.3.2. Europe Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.3. UK
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. UK Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.4. Germany
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Germany Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.5. France
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Target Disease Prevalence
      • 8.3.5.3. Competitive Scenario
      • 8.3.5.4. Regulatory Framework
      • 8.3.5.5. France Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.6. Italy
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Target Disease Prevalence
      • 8.3.6.3. Competitive Scenario
      • 8.3.6.4. Regulatory Framework
      • 8.3.6.5. Italy Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.7. Spain
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Target Disease Prevalence
      • 8.3.7.3. Competitive Scenario
      • 8.3.7.4. Regulatory Framework
      • 8.3.7.5. Spain Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.8. UK
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Target Disease Prevalence
      • 8.3.8.3. Competitive Scenario
      • 8.3.8.4. Regulatory Framework
      • 8.3.8.5. UK Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.9. Sweden
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Target Disease Prevalence
      • 8.3.9.3. Competitive Scenario
      • 8.3.9.4. Regulatory Framework
      • 8.3.9.5. Sweden Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.10. Norway
      • 8.3.10.1. Key Country Dynamics
      • 8.3.10.2. Target Disease Prevalence
      • 8.3.10.3. Competitive Scenario
      • 8.3.10.4. Regulatory Framework
      • 8.3.10.5. Norway Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.11. Denmark
      • 8.3.11.1. Key Country Dynamics
      • 8.3.11.2. Target Disease Prevalence
      • 8.3.11.3. Competitive Scenario
      • 8.3.11.4. Regulatory Framework
      • 8.3.11.5. Denmark Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. SWOT Analysis
    • 8.4.2. Asia Pacific Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. Japan Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.4.4. China
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. China Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.4.5. India
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. India Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.4.6. Australia
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Australia Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. Thailand Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.4.8. South Korea
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Target Disease Prevalence
      • 8.4.8.3. Competitive Scenario
      • 8.4.8.4. Regulatory Framework
      • 8.4.8.5. South Korea Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. SWOT Analysis
    • 8.5.2. Latin America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.5.3. Brazil
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. Brazil Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.5.4. Argentina
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Regulatory Framework
      • 8.5.4.5. Argentina Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.6. MEA
    • 8.6.1. SWOT Analysis
    • 8.6.2. MEA Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.6.3. South Africa
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. South Africa Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.6.4. Saudi Arabia
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. Regulatory Framework
      • 8.6.4.5. Saudi Arabia Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.6.5. UAE
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Regulatory Framework
      • 8.6.5.5. UAE Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.6.6. Kuwait
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Target Disease Prevalence
      • 8.6.6.3. Competitive Scenario
      • 8.6.6.4. Regulatory Framework
      • 8.6.6.5. Kuwait Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Share Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. F. Hoffmann-La Roche Ltd
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Siemens Healthcare Private Limited
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Abbott
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Beckman Coulter, Inc.
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Danaher Corporation
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Quest Diagnostics
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. EUROIMMUN Medizinische Labordiagnostika AG
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Nova Diagnostics Pte Ltd.
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. BIOMERIEUX
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Hemagen Diagnostics, Inc.
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Autoimmune Disease Diagnostics Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Autoimmune Disease Diagnostics Market, By Type, 2018 - 2030 (USD Million)
  • Table 5 Global Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 6 Global Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 7 Global Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 8 North America Autoimmune Disease Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Autoimmune Disease Diagnostics Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 North America Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 11 North America Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 12 North America Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 14 U.S. Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 15 U.S. Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 16 U.S. Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 17 Canada Autoimmune Disease Diagnostics Market, By Type, 2018 - 2030 (USD Million)
  • Table 18 Canada Autoimmune Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 19 Canada Autoimmune Disease Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Table 20 Canada Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 21 Mexico Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 22 Mexico Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 23 Mexico Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 24 Mexico Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 25 Europe Autoimmune Disease Diagnostics Market, by country, 2018 - 2030 (USD Million)
  • Table 26 Europe Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 Europe Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 28 Europe Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 29 Europe Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 30 UK Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 31 UK Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 32 UK Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 33 UK Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 34 Germany Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 35 Germany Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 36 Germany Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 37 Germany Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 38 France Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 39 France Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 40 France Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 41 France Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 42 Italy Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 43 Italy Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 44 Italy Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 45 Italy Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 46 Spain Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 47 Spain Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 48 Spain Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 49 Spain Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 50 Sweden Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 51 Sweden Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 52 Sweden Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 53 Sweden Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 54 Norway Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 55 Norway Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 56 Norway Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 57 Norway Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 58 Denmark Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 59 Denmark Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 60 Denmark Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 61 Denmark Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Autoimmune Disease Diagnostics Market, by country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 67 Japan Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 68 Japan Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 69 Japan Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 70 Japan Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 71 China Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 72 China Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 73 China Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 74 China Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 75 India Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 76 India Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 77 India Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 78 India Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 79 Australia Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 80 Australia Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 81 Australia Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 82 Australia Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 83 Thailand Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 84 Thailand Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 85 Thailand Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 86 Thailand Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 87 South Korea Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 88 South Korea Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 89 South Korea Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 90 South Korea Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 91 Latin America Autoimmune Disease Diagnostics Market, by country, 2018 - 2030 (USD Million)
  • Table 92 Latin America Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 93 Latin America Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 94 Latin America Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 95 Latin America Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 96 Brazil Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 97 Brazil Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 98 Brazil Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 99 Brazil Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 100 Argentina Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 101 Argentina Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 102 Argentina Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 103 Argentina Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 104 MEA Autoimmune Disease Diagnostics Market, by country, 2018 - 2030 (USD Million)
  • Table 105 MEA Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 106 MEA Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 107 MEA Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 108 MEA Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 109 South Africa Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 110 South Africa Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 111 South Africa Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 112 South Africa Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 117 UAE Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 118 UAE Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 119 UAE Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 120 UAE Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD)
  • Table 122 Kuwait Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Autoimmune Disease Diagnostics Market, By End Use, 32018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Autoimmune Disease Diagnostics Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 Penetration & Growth Prospect Mapping
  • Fig. 12 Swot Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Autoimmune Disease Diagnostics Market: Type Outlook and Key Takeaways
  • Fig. 15 Autoimmune Disease Diagnostics Market: Type Movement Analysis & Market Share 2024 & 2030
  • Fig. 16 Implementation Of the Amp Ra/SLE Program, By Research Phase
  • Fig. 17 Global Systemic Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 18 Global Rheumatoid Arthritis Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 19 Global Ankylosing Spondylitis Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 20 Global Systemic Lupus Erythematosus (SLE) Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 21 Global Other Systemic Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 22 Global Localized Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 23 Global Multiple Sclerosis Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 24 Global Type 1 Diabetes Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 25 Global Hashimoto's Thyroiditis Diagnostics Market, 2013 - 2025 (USD Millio2018 - 2030 (USD Million)
  • Fig. 26 Global Idiopathic Thrombocytopenic Purpura Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 27 Global Other Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 28 Autoimmune Disease Diagnostics Market: Product Outlook and Key Takeaways
  • Fig. 29 Autoimmune Disease Diagnostics Market: Product Movement Analysis & Market Share
  • Fig. 30 Global Instruments Market, 2018 - 2030 (USD Million)
  • Fig. 31 Global Consumables and Assays Tests Market, 2018 - 2030 (USD Million)
  • Fig. 32 Autoimmune Disease Diagnostics Market: Test Type Outlook and Key Takeaways
  • Fig. 33 Autoimmune Disease Diagnostics Market: Test Type Movement Analysis & Market Share
  • Fig. 34 Global Antinuclear Antibody Tests Market, 2018 - 2030 (USD Million)
  • Fig. 35 Global Autoantibody Tests Market, 2018 - 2030 (USD Million)
  • Fig. 36 Global C-Reactive Protein (CRP) Market, 2018 - 2030 (USD Million)
  • Fig. 37 Global Complete Blood Count (CBC) Market, 2018 - 2030 (USD Million)
  • Fig. 38 Global Urinalysis Market, 2018 - 2030 (USD Million)
  • Fig. 39 Global Others Market, 2018 - 2030 (USD Million)
  • Fig. 40 Autoimmune Disease Diagnostics Market: End Use Outlook and Key Takeaways
  • Fig. 41 Autoimmune Disease Diagnostics Market: End Use Movement Analysis & Market Share
  • Fig. 42 Global Hospitals Market, 2018 - 2030 (USD Million)
  • Fig. 43 Global Diagnostic Centres Market, 2018 - 2030 (USD Million)
  • Fig. 44 Global Others Market, 2018 - 2030 (USD Million)
  • Fig. 45 Regional Marketplace: Key Takeaways
  • Fig. 46 Regional Outlook, 2024 & 2030
  • Fig. 47 Regional Market Dashboard
  • Fig. 48 Regional Market Place: Key Takeaways
  • Fig. 49 North America, Swot Analysis
  • Fig. 50 Europe, Swot Analysis
  • Fig. 51 Asia Pacific, Swot Analysis
  • Fig. 52 Latin America, Swot Analysis
  • Fig. 53 MEA, Swot Analysis
  • Fig. 54 North America
  • Fig. 55 North America Autoimmune Disease Diagnostics Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 56 U.S. Key Country Dynamics
  • Fig. 57 U.S. America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 58 Canada Key Country Dynamics
  • Fig. 59 Canada America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 60 Mexico Key Country Dynamics
  • Fig. 61 Mexico America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 62 Europe America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 63 UK Key Country Dynamics
  • Fig. 64 UK America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 65 Germany Key Country Dynamics
  • Fig. 66 Germany America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 67 France Key Country Dynamics
  • Fig. 68 France America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 69 Italy Key Country Dynamics
  • Fig. 70 Italy America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 71 Spain Key Country Dynamics
  • Fig. 72 Spain America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 73 Sweden Key Country Dynamics
  • Fig. 74 Sweden America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 75 Norway Key Country Dynamics
  • Fig. 76 Norway America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 77 Denmark Key Country Dynamics
  • Fig. 78 Denmark America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 79 Asia Pacific America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 80 Japan Key Country Dynamics
  • Fig. 81 Japan America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 82 China Key Country Dynamics
  • Fig. 83 China America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 84 India Key Country Dynamics
  • Fig. 85 India America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 86 Australia Key Country Dynamics
  • Fig. 87 Australia America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 88 Thailand Key Country Dynamics
  • Fig. 89 Thailand America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 90 South Korea Key Country Dynamics
  • Fig. 91 South Korea America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 92 Latin America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 93 Brazil Key Country Dynamics
  • Fig. 94 Brazil America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 95 Argentina Key Country Dynamics
  • Fig. 96 Argentina America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 97 Middle East and Africa America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 98 South Africa Key Country Dynamics
  • Fig. 99 South Africa America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 100 Saudi Arabia Key Country Dynamics
  • Fig. 101 Saudi Arabia America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 102 UAE Key Country Dynamics
  • Fig. 103 UAE America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 104 Kuwait Key Country Dynamics
  • Fig. 105 Kuwait America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 106 Strategy Mapping